Imagine you test early and often for a condition in country A much more often than country B which waits until some more late stage easier to detect symptoms occur. Now compare survivor rates. Much higher in country A! We should clearly also be testing in country B, right?
Depends. If the condition is something that doesn’t often actually kill and typically remains at a non lethal but detectable state then all you might have done is treat a lot of extra non fatal conditions that usually only is detected in country B once it evolves to a more advanced and dangerous state. You may have put many people in country A through an unnecessary, expensive, and frightening treatment regime.
The point is that these things are complex and need thorough analysis.
Why? Imagine 1 million people get tested. Well we know exactly 1 person (on average) in that group is going to have the disease. But our 99% accurate test will ring a positive 1%, or 10,000 times. So the odds that you really have the disease are the odds that you're that 1 in 10,000 which is 99.99% against! Well just run the test again. Oh no! It turns up positive again! What are the odds it's two false positives? 99%! Same math. Now we know that 1 person has the disease, but our test will show 1%, 100 people, in the 10,000 as being positive. So your odds of having it are 1 in 100, or 99% against.
I'm not especially interested in being tested for rare conditions.